Efavirenz: a decade of clinical experience in the treatment of HIV

Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA

(2009) Wendy P Bannister et al.   AIDS

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

(2009) Richard H Haubrich et al.   AIDS

A Randomized Comparative Trial of Continued Zidovudine/Lamivudine or Replacement With Tenofovir Disoproxil Fumarate/Emtricitabine in Efavirenz-Treated HIV-1-Infected Individuals

(2009) Martin Fisher et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

(2008)   AIDS

The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients

(2008) Joel E Gallant et al.   AIDS

Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy

(2008) James H Willig et al.   AIDS

Efavirenz concentrations in HIV-infected patients with and without viral hepatitis

(2008) Sofia A. Pereira et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Virologic, Immunologic, Clinical, Safety, and Resistance Outcomes from a Long-Term Comparison of Efavirenz-Based Versus Nevirapine-Based Antiretroviral Regimens as Initial Therapy in HIV-1—Infected Persons

(2008) Mary van den Berg-Wolf et al.   HIV CLINICAL TRIALS

Impact of Switching Virologically Suppressed, HIV-1-Infected Patients from Twice-Daily Fixed-Dose Zidovudine/Lamivudine to Once-Daily Fixed-Dose Tenofovir Disoproxil Fumarate/Emtricitabine

(2008) Edwin DeJesus et al.   HIV CLINICAL TRIALS

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

(2008) BG Gazzard et al.   HIV MEDICINE

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults

(2008) N Clumeck et al.   HIV MEDICINE

Treatment Outcome and Cost-Effectiveness of Different Highly Active Antiretroviral Therapy Regimens in the Uk (1996–2002)

(2008) E J Beck et al.   INTERNATIONAL JOURNAL OF STD & AIDS

The Relationship Between Resistance and Adherence in Drug-Naive Individuals Initiating HAART Is Specific to Individual Drug Classes

(2008) Lily W Y Tam et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Antiretroviral Treatment of Adult HIV Infection

(2008) Scott M. Hammer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population

(2008) Krishnan Bhaskaran   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The role of efavirenz compared with protease inhibitors in the body fat changes associated with highly active antiretroviral therapy

(2008) J. A. Perez-Molina et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort

(2008) P. Domingo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz

(2008) J. M. Llibre et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

(2008) C. Wyen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacokinetics of Efavirenz When Co-administered With Rifampin in TB/HIV Co-infected Patients: Pharmacogenetic Effect ofCYP2B6Variation

(2008) Awewura Kwara et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Efavirenz‐Based Regimens in Treatment‐Naive Patients with a Range of Pretreatment HIV‐1 RNA Levels and CD4 Cell Counts

(2008) Heather J. Ribaudo et al.   JOURNAL OF INFECTIOUS DISEASES

Phase II Study of Vicriviroc versus Efavirenz (both with Zidovudine/Lamivudine) in Treatment‐Naive Subjects with HIV‐1 Infection

(2008) Raphael J. Landovitz et al.   JOURNAL OF INFECTIOUS DISEASES

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

(2008) Sharon A. Riddler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Not All Missed Doses Are the Same: Sustained NNRTI Treatment Interruptions Predict HIV Rebound at Low-to-Moderate Adherence Levels

(2008) Jean-Jacques Parienti et al.   PLoS One

Association between Exposure to Nevirapine and Reduced Liver Fibrosis Progression in Patients with HIV and Hepatitis C Virus Coinfection

(2007) J. Berenguer et al.   CLINICAL INFECTIOUS DISEASES